There is a high-quality talent pool in the specialist area of pharma engineering design in India Read more
Inflation, drug pricing and reimbursement constraints will have the biggest negative impact on biopharma industry in 2023: GlobalData Read more
Pricing pressures and regulatory overhang affect margins of Indian pharma companies in FY2023: ICRA Read more
Alembic Pharma receives USFDA’s final approval for Fesoterodine Fumarate extended-release tablets Read more
USFDA accepts AstraZeneca’s BLA for nirsevimab to prevent RSV lower respiratory tract disease Read more